RK
Rajeev Kumar Giri
About Rajeev Kumar Giri
Data last updated:
Rajeev Kumar Giri is a Director at Ribozelle Meds Private Limited (since 2024) and Designated Partner at Genetico Drugs Llp (since 2021). The companies operate in Paper and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 May 2024 | 2024 | Active | ||
| Designated Partner | 21 Aug 2021 | 2019 | Active |
Board colleagues of Rajeev Kumar Giri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Darakshan Yusufi | 08458973 | Ribozelle Meds Private Limited , Genetico Drugs Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Kumar Giri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Kumar Giri
Rajeev Kumar Giri currently holds 2 directorships: Ribozelle Meds Private Limited (Director, since 26 May 2024); Genetico Drugs Llp (Designated Partner, since 21 Aug 2021).
Rajeev Kumar Giri was first appointed on 21 Aug 2021 as Designated Partner at Genetico Drugs Llp. The most recent appointment on record is 26 May 2024 at Ribozelle Meds Private Limited.
The current boards of Rajeev Kumar Giri's companies include Darakshan Yusufi (Ribozelle Meds Private Limited).